Europe Sleep Apnea Devices Market

The report "Europe Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostic {PSG, Home Sleep Testing, Oximeter}], Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings]–Forecast To 2031" is projected to grow from USD 1.88 billion in 2026 and to reach USD 2.69 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period.

Browse 130 market data Tables and 59 Figures spread through 200 Pages and in-depth TOC on "Europe Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostic {PSG, Home Sleep Testing, Oximeter}], Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings]–Forecast To 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-sleep-apnea-devices-market-261326440.html

The market for sleep apnea devices in Europe has undoubtedly seen significant growth. The rise of home sleep testing equipment has been a major driver of this growth, as it provides a more efficient option for individuals with sleep disorders to receive timely treatment. With the rise of digital health technologies and other monitoring technologies in healthcare, the primary issues of healthcare access are being addressed effectively in various nations of Europe. Although lower levels of adherence to CPAP therapy are a major objective of concern, the continuous development of sleep apnea devices is anticipated to positively impact the market for sleep apnea devices in Europe and create growth opportunities.

Home care settings was the largest segment of the European sleep apnea devices market in 2025.

The market is segmented by end users, including home care settings, hospitals, sleep clinics, ambulatory care centers, primary care facilities, and others. The home care segment holds the largest share of the European sleep apnea devices market, driven by rising demand for home-based diagnosis and treatment of sleep apnea across Europe. The growing use of home sleep tests and PAP therapy equipment has reduced the need for sleep apnea treatment in hospitals or sleep clinics. Rising patient demand for the benefits of home-based sleep apnea treatment, along with efforts by the healthcare system in many European countries, has further increased demand for the home segment in the European sleep apnea devices market.

In 2025, the therapeutic devices segment remained the largest segment of the European sleep apnea devices market overall.

This market segment can be divided into therapeutic devices and diagnostic devices. The former dominates the sleep apnea devices market due to its crucial role in the long-term management of sleep apnea. This dominance is driven by continuous technological advances that improve the effectiveness of Positive Airway Pressure (PAP) devices, masks, and associated devices, combining comfort, portability, and simplicity for patients. Philips (The Netherlands), ResMed (US), Fisher & Paykel Healthcare (New Zealand), among others, have contributed greatly to this segment, thus contributing to their prominent positioning in the sleep apnea devices market.

The key players in the Europe sleep apnea devices market include companies such as Philips (Netherlands), ResMed (US), Inspire Medical Systems (US), Fisher & Paykel Healthcare (New Zealand), Compumedics Limited (Australia), SomnoMed (Australia), and ProSomnus Sleep Technologies (US).

Don’t miss out on business opportunities in Europe Sleep Apnea Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/